Related Experiment Video
Updated: Aug 9, 2026

Characterizing Modulators of Protease-Activated Receptors with a Calcium Mobilization Assay Using a Plate Reader
Published on: May 24, 2024
CRIT peptide interacts with factor B and interferes with alternative pathway activation
Kwok-Min Hui1, Bergljót Magnadóttir, Jürg A Schifferli
1University Hospital Basel, Immunonephrology, Department of Research, Hebelstrasse 20, CH-4031 Basel, Switzerland. 12min@mail.hongkong.com
Insights
Complement C2 receptor inhibitor trispanning (CRIT) peptide CRIT-H17 blocks alternative pathway (AP) complement activation by inhibiting factor B cleavage. This peptide shows potential for modulating AP-driven inflammatory diseases.
Area of Science:
- Immunology
- Complement system biology
Background:
- Complement C2 receptor inhibitor trispanning (CRIT) targets the classical pathway (CP) C3 convertase.
- The C-terminal peptide CRIT-H17 mimics C4b binding to C2.
- Similarities exist between CP and alternative pathway (AP) C3 convertases.
Purpose of the Study:
- To investigate the effect of CRIT-H17 on the AP of the complement system.
- To determine the mechanism of CRIT-H17 inhibition on AP activation.
Main Methods:
- ELISA and immunoblot assays to detect CRIT-H17 binding to factor B (FB).
- Inhibition assays for factor D-mediated cleavage of FB.
- Hemolytic assays using C2-deficient serum to assess AP activation.
Main Results:
- CRIT-H17 blocked factor D-mediated cleavage of factor B.
- CRIT-H17 directly bound to factor B.
- CRIT-H17 did not affect C3bB complex assembly or exhibit decay-accelerating activity.
- CRIT-H17 inhibited AP complement activation in a hemolytic assay.
Conclusions:
- CRIT-H17 peptide inhibits AP complement activation by interfering with factor B function.
- CRIT-H17 represents a potential therapeutic agent for AP-mediated diseases.
Abstract:
Complement C2 receptor inhibitor trispanning (CRIT) inhibits the classical pathway (CP) C3 convertase formation by competing with C4b for the binding of C2. The C-terminal 11-amino-acid of the first CRIT-extracellular domain (CRIT-H17) has a strong homology with a sequence in the C4beta chain, which is responsible for the binding of C2. Since the CP and alternative pathway (AP) C3 convertases have many functional and structural similarities, we further investigated the effects of CRIT-H17 on the AP. The factor D-mediated cleavage of factor B (FB) was blocked by CRIT-H17. By ELISA and immunoblot, CRIT-H17 was shown to bind FB. CRIT-H17 had no decay activity on the C3bBb complex as compared to decay-accelerating factor. Binding of CRIT-H17 to FB did not interfere with the assembly of C3bB complex. In a haemolytic assay using C2-deficient serum, CRIT-H17 interfered with AP complement activation.
More Related Videos
Related Concept Videos
TGF - β Signaling Pathway
The Intrinsic Apoptotic Pathway
Intracellular Signaling Affects Focal Adhesions
Some...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Complement System
Determinants of Bacterial Pathogenicity and Virulence

